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Abstract
Background: Many patients suffer from severe shoulder complaints after breast cancer surgery 
and axillary lymph node dissection. Physiotherapy has been clinically observed to improve 
treatment of these patients. However, it is not a standard treatment regime. The purpose of this 
study is to investigate the efficacy of physiotherapy treatment of shoulder function, pain and quality 
of life in patients who have undergone breast cancer surgery and axillary lymph node dissection.
Methods: Thirty patients following breast cancer surgery and axillary lymph node dissection were 
included in a randomised controlled study. Assessments were made at baseline and after three and 
six months. The treatment group received standardised physiotherapy treatment of advice and 
exercises for the arm and shoulder for three months; the control group received a leaflet 
containing advice and exercises. If necessary soft tissue massage to the surgical scar was applied. 
Primary outcome variables were amount of pain in the shoulder/arm recorded on the Visual 
Analogue Scale, and shoulder mobility (flexion, abduction) measured using a digital inclinometer 
under standardized conditions.
Secondary outcome measures were shoulder disabilities during daily activities, edema, grip strength 
of both hands and quality of life. The researcher was blinded to treatment allocation.
Results: All thirty patients completed the trial. After three and six months the treatment group 
showed a significant improvement in shoulder mobility and had significantly less pain than the 
control group. Quality of life improved significantly, however, handgrip strength and arm volume 
did not alter significantly.
Conclusion: Physiotherapy reduces pain and improves shoulder function and quality of life 
following axillary dissection after breast cancer.
Trial registration: ISRCTN3II86536
Open Access
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Background
According to the European Network of Cancer Registra­
tion (1999) the incidence of breast cancer in women in 
the Netherlands is the highest in Europe with figures of 
120/100,000. The mean age at which breast cancer is 
detected is 60 years [1]. Approximately 40% of these 
women have a metastasis in the axillary lymph nodes, 
indicating that cancer has possibly spread beyond the 
breast. The axillary lymph node dissection (ALND) carries 
a high morbidity, however, as a result of the sentinel node 
procedure the number of patients with ALND is decreas­
ing. Following surgery with ALND, 73% of women 
reported restricted shoulder mobility, tightness, edema, 
pain, numbness of the arm, and limitations in daily life 
[2,3]. These complaints could be due to tissue and nerve 
damage. In general, the arm-related complaints usually 
decrease within three months [4,5]. However, they may 
also become chronic. The extent of the problem is often 
underestimated. A study addressing quality of life in 
patients with breast cancer showed that 74% of the 
women felt that the ALND had adversely affected their 
lives [6]. Scar tissue, edema, numbness and possible bra­
chial plexus traction could be the cause. An investigation 
of recovery of upper limb function after ALND in 76 
women by Gosselink et al. showed that three months fol­
lowing surgery, upper limb function is still impaired in a 
significant number (27%) of patients [7].
Unrelated to breast cancer, there is a high prevalence (7­
36%) of musculoskeletal shoulder disorders in the popu­
lation resulting in considerable pain and disability. Phys­
iotherapy is often the first choice of treatment and has 
been proven to be effective for these shoulder disorders 
[8]. However, there is no evidence of the efficacy and 
effectiveness of physiotherapy for shoulder complaints 
related to breast cancer and ALND. Karki et al. deducted 
from their review that physiotherapy could play an impor­
tant role in the post-operative treatment of patients with 
shoulder/arm complaints following breast cancer surgery 
[5]. Furthermore, Box et al. concluded in their RCT that a 
postoperative physiotherapeutic protocol is effective in 
facilitating and maintaining the recovery of shoulder 
movement [9]. The authors of the review found no evi­
dence showing that the start of early exercises is beneficial. 
One of the few randomized studies concerning the effect 
of physiotherapy in patients after breast cancer with 
ALND showed that physiotherapy leads to a faster func­
tional recovery of the arm [10]. However, follow-up time 
was short (one to three months). A recent randomized 
study by Lauridsen et al. (2005), (n = 139), showed a sig­
nificant improvement of shoulder function after they 
received team instructed physiotherapy [11]. This study 
also indicated that patients with breast-conserving ther­
apy showed less severe and less frequent shoulder prob­
lems than patients with modified radical mastectomy.
Besides the type of surgery the effect of physiotherapy was 
influenced by adjuvant radiation therapy.
There is no standard referral for physiotherapy following 
ALND and the disabilities of pain and shoulder dysfunc­
tion following this surgery can be severe. The aim there­
fore of this research is to gain insight into the efficacy of 
physiotherapy following breast cancer with ALND. The 
primary measures included shoulder mobility, shoulder 
and arm function and pain, with quality of life also being 
assessed.
Methods
The efficacy of physiotherapy was assessed in a prospec­
tive study by comparing two groups of patients who were 
randomly assigned to a physiotherapy group (exercise 
therapy) or to a control group. The study was performed 
from July 2003 to January 2005 and patients enrolled 
between August 2003 and June 2004. Patients were 
recruited from the Radboud University Nijmegen Medical 
Centre (RUNMC) and the Canisius Wilhelmina Hospital 
(CWZ) Nijmegen in The Netherlands. Patients with breast 
cancer having to undergo surgery with ALND, were con­
sidered eligible for the study and had to meet the follow­
ing criteria: 18 years of age and older with an ALND, 
following breast cancer, a Visual Analogue Scale (VAS; 0­
10) pain score of 1 or more and moderate shoulder disa­
bilities in daily life (minimal 3 points on a 5 points disa­
bility score list). Patients were excluded with a previous 
contra-lateral breast cancer surgery and insufficient 
knowledge of the Dutch language to fill in the question­
naires. Informed consent was obtained from all subjects, 
and the regional medical ethics board approved the study.
Patients were given a subject information sheet by a mem­
ber of the nursing staff during their hospital stay. Patients 
who were willing to participate in the trial attended the 
Department of Physiotherapy for physical assessments 
two weeks after surgery, which was concurrent to the first 
outpatient clinic visit to the surgeon. Baseline measure­
ments were assessed and patients who met the inclusion 
criteria signed an informed consent. Random assignment 
was done by an independent co-worker of the department 
into one of the two groups. The treatment group received 
specific physiotherapy treatment and the control group 
had no physiotherapy. Concealed randomization was 
achieved using a computer-generated random list, which 
was kept by the co-worker. All assessments were done at 
the RUMC Department of Physiotherapy by a single 
researcher, who did not participate in the treatment of the 
patients. The researcher was blinded to the treatment allo­
cation and patients were instructed not to discuss their 
treatment with the researcher. The researcher made a note 
after the final assessment, to which group allocation that 
she thought the patient belonged.
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Intervention
Control group
Patients assigned to the control group received a leaflet 
flyer with advice and exercises for the arm/shoulder for 
the first weeks following surgery and had no further con­
tact with a physiotherapist.
Physiotherapy group
Patients assigned to the treatment group started physio­
therapy two weeks following surgery in a private practice 
of their own choice. The research assistant contacted the 
individual physiotherapists (n = 15) who had agreed to 
comply with the treatment regime and supplied them 
with information regarding the project and treatment 
guidelines. This information consisted of:
- guidelines with advice and exercises for arm/shoulder, 
posture correction, coordination exercises, exercises for 
muscular strength and improvement of general physical 
condition [12];
- exercises to prevent lymph edema [13];
- instruction for soft tissue massage of the surgical scar if 
required;
- a form to report the content of the treatment sessions 
and a 3-point scale to indicate whether the amount of 
treatment sessions was sufficient.
The total number of treatments was nine (nine being usu­
ally covered by the healthcare insurance), once or twice 
weekly for the first three weeks, and thereafter once a fort­
night or less. The total amount of sessions had to be given 
within three months. Patients were asked to perform 
home exercises for ten minutes each day.
Measurements
Demographic data was recorded (age, general health) and 
as well as data and information about the level of impair­
ment, disability and participation at baseline and after 
three and six months in both groups.
The primary outcome variables were pain in the shoulder/ 
arm, measured using the VAS score (0 -  10, 0 = no pain; 
10 = unbearable pain) and shoulder mobility (flexion [0­
180°], abduction [0-180°]), measured by use of a digital 
inclinometer under standardized conditions.
Secondary outcome measures were disabilities in daily 
life, measured by the DASH (Disabilities of the Arm, 
Shoulder and Hand) questionnaire [14] (0 -  100, 0 = no 
functional problems, 100 = maximal problems), edema 
(ml), measured in both arms by means of water displace­
ment, grip strength (Kg) of both hands, measured using
the hand-held dynamometer and quality of life, as meas­
ured by the SIP (Sickness Impact Profile-short version) 
questionnaire (0 -  68, 0 = good health status; 68 = severe 
physically disabled) [15]. The total amount of time for 
each measurement session was approximately 40 min­
utes, measurements taking place prior to randomization 
at intake and at three and six months following intake.
Statistics
Data was analyzed using the SPSS version 12.1. Univariate 
analysis of variance was used to test differences in out­
come variables between the control group and physio­
therapy group. Baseline data were entered in the analysis 
as co-variates. Level of significance was set at 0.05.
Results
Thirty-six women with breast cancer surgery and ALND 
were operated during the trial. Six patients did not give 
informed consent as they were convinced that they 
needed physiotherapy and did not want to take the risk to 
be placed in the control group. Thirty-two women with 
ALND were eligible for inclusion. Two were excluded 
because they experienced no pain, no shoulder immobil­
ity, and no shoulder disabilities. Thirty women, (mean 
age 55, SD 11, range 34-82) completed the study proto­
col. In the follow-up period one patient from the control 
group died before the last assessment. None of the control 
group received physiotherapy treatment. There were no 
differences in patient characteristics between both groups 
at baseline (see Table 1), nor were there any substantial 
differences in type of adjuvant therapy between the inter­
vention and control group (Table 2). Functional shoulder 
impairments and pain in the shoulder/arm were reduced 
significantly after physiotherapy treatment (both p < 
0.001) at three months compared with the control group 
(Tables 3 and 4). In the treatment group the pain 
decreased on the VAS by 3.4 points in the treatment group 
(from 4.7 to 1.3), in contrast with a 0.5 point decrease in 
the control group (from 4.2 to 3.7). Both shoulder flexion 
and abduction had increased in the intervention group 
(respectively p = 0.003 and p = 0.005). Shoulder flexion 
increased in the treatment group by 45 degrees and abduc­
tion by 70 degrees versus 11 and 13 degrees respectively in 
the control group. There was no significant improvement 
in handgrip strength between both groups (p = 0.08). Vol­
ume of the related arm showed no significant difference 
between both groups at baseline and follow-up (p = 0.88).
Ten patients in the treatment group improved, in partici­
pation in social activities and less avoiding heavy work 
around the house (SIP: p = 0.035). The DASH showed an 
improvement of shoulder mobility and shoulder/arm dis­
abilities in the treatment group (p = 0.017). For an over­
view of the effect sizes see Table 4.
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T a b le  1: P a tie n t c h a ra c te r is tic s  o f  in te rv e n t io n  g ro u p  (n = 15) and 
c o n tro l g ro u p  (n  = 15) a t  base line , no  s ig n ific a n t d iffe re n ce s  
p re s e n t b e tw e e n  b o th  g roups
Intervention 
group (n = i5) 
n
C on tro l group
(n = i 5)
n
Age (mean, SD) 53.7 (SD i3.G) 55.4 (SD 9.3)
Affected side
Dominant 6 7
Non dominant 9 8
Pre-existing shoulder 
complaints
None i3 i2
Rheumatoid Arthritis i 3
Epicondylitis i G
Surgery
Breast-conserving and ALND 3 4
Mastectomy and ALND i 2 i i
N um ber o f extirpated lymph 
nodes
1 -  10 nodes 2 2
11 -  21 nodes 3 i
>21 nodes iG i2
Post-surgery complications
None 8 9
Seroma 4 3
Infection i 3
Bleeding 2 G
Hospital
Radboud University M C i i iG
C W Z  hospital 4 5
Comparison of both groups at six months after intake 
showed that, except for the SIP, the above-mentioned 
improvements continued. All physiotherapists who 
treated patients in the intervention group reported that 
they had complied with the given instructions and exer­
cises (passive, assisted and active) in nine sessions. Ten 
(66%) physiotherapists had applied soft tissue massage to 
the surgical scar, two used (13%) lymph drainage for min-
T a b le  2: A d ju v a n t th e ra p y  o f  in te rv e n t io n  g ro u p  (n  = 15) and 
c o n tro l g ro u p  (n  = 15)
Intervention 
group (n = I5) 
n
C on tro l group
(n = 15)
n
None 3 G
Radiation therapy (RT) G 2
Chem otherapy 2 2
Horm onal therapy i i
Radiation therapy and 
chemotherapy
6 8
C hem otherapy and hormonal 
therapy
i i
Radiation and hormonal therapy i i
Radio, chemo and hormonal 
therapy
i G
imization of edema and four (26%) physiotherapists 
started with exercises to improve the general physical con­
dition. Eleven (73%) physiotherapists indicated that the 
number of treatment sessions was sufficient, three (20%) 
that the number was insufficient and one (7%) that the 
number was too high. Seven of the eleven physiothera­
pists indicated that further treatment continuation could 
be beneficial for the improvement of the general physical 
condition. The researcher was successfully blinded for 
treatment allocation of patients; in 60% of the cases treat­
ment allocation was guessed correctly.
Discussion
This study showed that physiotherapy, which began two 
weeks after surgery, improved shoulder function and 
quality of life and reduced shoulder pain in patients with 
axillary dissection in breast cancer with substantial effect 
sizes. Handgrip strength showed a positive trend, however 
this was not markedly impaired postoperatively. The vol­
ume of the related arm showed little change with edema 
commonly occurring at a later stage after surgery. Signifi­
cant improvement in the psychosocial situation was 
measured by the SIP. Despite the fact that this question­
naire is not a disease specific instrument, it gives a general 
idea about how patients cope in daily life. Most patients 
indicated at intake that they avoided social activities and 
this improved greatly following therapy.
A sample size calculation was not performed for pain and 
shoulder mobility in breast cancer patients as insufficient 
information was available. Outcomes of this study may be 
used for calculations in a larger effect study, as there are 
currently no available gold standards.
Treatment plan
Eleven physiotherapists considered the number of treat­
ment sessions to be sufficient for improvement of shoul­
der function, however, seven of these physiotherapists 
reported that further treatment continuation could be 
beneficial for the improvement of the general physical 
condition. Nine physiotherapy treatments were opted for, 
due to the fact that Dutch medical insurance at the time of 
the study mostly covered the costs for this number of ses­
sions and Harris et al. recommend in their Clinical Prac­
tice Guidelines fewer than 12 visits [13]. However, these 
guidelines are empirical and not evidence based. The liter­
ature is not consistent in the amount of physiotherapeutic 
treatments and the time period. The time period in this 
study varies from one to three months and the frequency 
from once to three times a week. Further insight in the 
optimal treatment frequency and duration is warranted.
While most authors agree that physiotherapy treatment 
should begin immediately post-operatively, this is not 
supported by scientific evidence. Other authors suggest
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In te rv e n t io n  g ro u p C o n t ro l g ro u p
(n = 15) (n = 15) (n = 14)
T 0 T l T 2 T 0  T l T 2
O utcom e M ean (S D ) M e an  (S D )
Functional shoulder impairments (1 -5) 3.7 (0.6) 1.7 (0.5) 1.4 (0.8) 2.9 (0.6) 3.1 (0.7) 2.4 (0.6)
VAS fo r pain (0 -10) 4.7 (1.6) 1.3 (1.2) 0.9 ( I . I ) 4.2 (1.8) 3.7 ( l.6 ) 3.2 ( l.8 )
Handgrip strength (Kg) 26.0 (7.1) 30.0 (6.3) 30.0 (7.0) 24.7 ( l 0.5) 25.7 ( l l . l ) 26.7 ( l0 . l )
A nteflexion shoulder (0-180°) I2 I (23.5) 166 (10.1) 171 (13.5) 133 (24.1) 144 (27.0) l53 (22.7)
Abduction shoulder (0-180°) 96.5 (24.0) 167 ( l  5.2) 170 (l3 .5 ) 122 (28.9) l35 (38.8) l44  (34.3)
DASH (0-100) 48.6 ( l 8.6) 18.7 (12.7) 14.6 (10.7) 40.5 (20.3) 28.7 ( l9 . l ) 2 l .6 ( l 2.5)
SIP (0-68) 9.1 (6.8) 5.0 (4.5) 4.4 (4.7) 10.5 (9.1) l0 .l ( l0 .8 ) 8.0 (8.3)
Volume operated arm (ml) 255 (49.1) 261 (55.9) 268 (54.1) 259 (42.9) 263 (50.5) 272 (48.5)
VAS, Visual Analogue Scale; DASH, Disabilities o f the A rm , Shoulder and Hand; SIP, Sickness Impact Profile.
starting five to seven days following surgery this having a 
positive effect on wound healing [16,17]. Research with 
immediate and delayed onset (3 to 14 days) of exercises 
showed that benefits of starting early exercises are only 
marginal [4,16,17]. Lauridsen et al. (2005) showed that, 
despite patients having postoperative physiotherapy dur­
ing the first week in hospital, there was compromised 
shoulder function at seven weeks postoperatively. This 
improved after 12 sessions of physiotherapy, even when 
the therapy started after 6 months.
Ajuvant therapy
The current study size limits conclusions concerning the 
efficacy of physiotherapy in combination with chemo­
therapy and radiotherapy. The literature also shows that 
no conclusion can be made about the best training inten­
sity and duration during chemotherapy and radiation 
therapy [5]. Future research is needed to examine the
effectiveness of these rehabilitation programs. However, 
adjuvant treatment like radiation seemed to influence the 
effect on physiotherapy. The subgroup with patients hav­
ing a breast cancer surgery with ALND and radiation after 
physiotherapy did not improve their shoulder function 
significantly. However, Karki et al. [5] suggest that apply­
ing physiotherapy during or after radiation may be of ben­
efit.
Limitations
Besides the small sample size, a limitation of the study is 
the short follow-up time of six months. A long-term fol­
low-up will provide further information about the lasting 
improvement and the occurrence of lymph edema follow­
ing ALND. The systematic review of Karki et al. [5] indi­
cated that lymph edema can commence one month to 28 
years following surgery. We also found that physiotherapy 
groups had a significantly improved range of shoulder
T a b le  4: E ffe c t sizes o f  in te rv e n t io n  g ro u p  c o m p a re d  to  c o n tro l g ro u p  on  d e te rm in e d  va ria b les
E ffe c t s izesa
T 0  vs. T l T 0  vs. T 2
Value (95% CI) Sign (P) Value (95% CI) Sign (P)
Functional impairments ( l -  5) - 1.8 (-2.3 -  - 1.3) < 0 .001 -0.8 ( - 1.5 -  -0.2) 0 .0 18
VAS fo r pain (0 - l0 ) -2.7 (-3.6 -  - l  .9) < 0 .001 -2.5 (-3.5 -  - 1.6) <0 .001
Hand grip strength (Kg) 3.l (-0.4 -  6.6) 0 .081 l .4 (-2.4 -  5.2) 0.452
Anteflexion shoulder (0 - l8 0 ° ) 24.9 (9.3 -  40.5) 0.003 l9.3 (5.7 -  32.8) 0.007
Abduction shoulder (0 - l8 0 ° ) 36.7 ( 12.2 -  6 l .2) 0.005 29.7 (7.9 -  5 l .5) 0 .0 l0
DASH ( 0 - 100) - 13.5 (-24.3 -  -2.6) 0 .017 -9.0 (- l 7.2 -  -0.8) 0.032
SIP (0 -68) -4.0 (-7.7 -  -0.3) 0.035 -2.8 (-6.7 -  l .0) 0. l42
Volume operated arm (ml) l .6 (-20.2 -  23.5) 0.880 -0.6 (-20.7 -  l9.4) 0.950
a Effect sizes are calculated as differences between groups at T I o r  T2 adjusted fo r the TO assessment (entered as covariate in the analysis). 
VAS, Visual Analogue Scale; DASH, Disabilities o f the A rm , Shoulder and Hand; SIP, Sickness Impact Profile.
Page 5 of 6
(page number not for citation purposes)
BMC Cancer 2007, 7:166 http://www.biomedeentral.eom/1471-2407/7/166
motion when compared with the control group in all 
studies. However participating patients in the review had 
undergone breast cancer surgery with or without ALND. 
In contrast to the patient groups in the systematic review, 
the group in our study is homogeneous, i.e. all patients 
have had breast cancer with ALND.
At this time there is no standard referral for physiotherapy 
in cases of shoulder/arm related complaints. However, 
Voogd et al. (2003) found that physiotherapy is often pre­
scribed during follow-up, especially among patients with 
edema and restricted shoulder function [6]. Up to now 
there is insufficient evidence of the effectiveness of physi­
otherapy in this patient group over a longer period of 
time. Larger studies with at least a 1-year follow-up with 
relevant outcome measures, such as shoulder function, 
pain, quality of life and edema are needed. Nevertheless, 
based on our current findings, we argue that patients with 
shoulder complaints after ALND should be referred to a 
physiotherapist. Moreover, a functional shoulder assess­
ment by a physiotherapist at the first outpatient visit two 
weeks following breast cancer surgery with ALND is also 
recommended.
Conclusion
Physiotherapy reduces pain and improves shoulder func­
tion and quality of life following axillary dissection in 
breast cancer.
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